By Heidi Chen 30 Nov 2017
Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D
How it works
Our team of analysts gather all publicly available information on CFDA-approved clinical trial sites in China, and are constantly updating it as new CFDA approvals are announced.
Sitetrove, seamlessly integrated with every Chinatrove subscription, provides visibility into hospitals’ trial histories, investigator profiles and more.
Chinatrove aggregates data based on your individual search criteria, enabling you to generate a target list of sites, and view geographic distribution using analytic dashboards..
How it helps
With Chinatrove, you gain unparalleled access to key insights on healthcare institutions including:
Plus, you can benefit from China-based research support availability, and experienced investigator profiles through seamless integration with Sitetrove.
Be informed of CFDA-certified hospitals' trial activity by phase and status
Be confident that the hospital you choose meets your protocol demands
Instantly and easily generate custom tables and charts of key trial attributes
Know who you’re hiring participate in your trial program
By Christina DeRuzza 24 Nov 2017
China’s 13th five-year plan 2016–20 will move the country into the center of the international stage of drug development, where they will be global innovators in the industry and more competitive than ever with foreign firms.
By Christina DeRuzza 30 Mar 2016
The race for an approved non-interferon regimen to treat Hepatitis C Virus (HCV) infections in China is on and market stakes are high.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: